Barclays raised the firm’s price target on Axon to $222 from $177 and keeps an Overweight rating on the shares. The company delivered strong Q4 revenue, adjusted EBITDA and earnings, all materially ahead of estimates with growth in both reporting segments, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AXON: